United States
老虎證券
Invest
Pricing
Rewards
Support
Learn
About
Quotes
TigerAI
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
永泰生物-B
4.100
+0.150
3.80%
手動刷新
成交量:
14.70萬
成交額:
59.02萬
市值:
21.10億
市盈率:
-10.62
高:
4.100
開:
3.940
低:
3.900
收:
3.950
資料載入中...
總覽
公司
新聞
公告
阿斯利康(AZN.US)乳腺癌1類創新藥在中國獲批
智通财经
·
04-18
【國家藥監局批准卡匹色替片上市】近日,國家藥品監督管理局批准AstraZeneca UK Limited申報的1類創新藥卡匹色替片(商品名:荃科得(TRUQAP)),該藥適用於聯合氟維司羣用於轉移性階段至少接受過一種內分泌治療後疾病進展,或在輔助治療期間或完成輔助治療後12個月內復發的激素受體(HR)陽性、人表皮生長因子受體2(HER2)陰性且伴有一種或多種PIK3CA/AKT1/PTEN改變的局部晚期或轉移性乳腺癌成人患者。該藥品上市為患者提供了新的治療選擇。
金融界
·
04-18
武漢人福創新藥物研發中心有限公司藥品申請臨牀試驗默示許可獲受理
金融界
·
04-17
迪哲醫藥18億定增落地,多家機構搶籌入局
华尔街见闻
·
04-17
恒生醫療指數ETF飄紅,一脈陽光漲超12%,機構:持續看好A股、港股創新藥企出海進程
21世纪经济报道
·
04-17
復宏漢霖(02696)CEO朱儁:挖掘出創新藥“未被滿足的需求”,經濟效益將自顯
智通财经
·
04-17
國金證券:以BD出海關税風險小 看好創新藥國際化進程
智通财经
·
04-17
中證創新藥產業指數下跌0.73%,前十大權重包含復星醫藥等
金融界
·
04-16
港股異動 | 同源康醫藥-B(02410)尾盤漲超6% TY-9591入選ASCO本土創新藥企實現技術突破
智通财经网
·
04-16
【華泰證券:AI醫療產業趨勢正在加速】華泰證券研報表示,4月10日,美國FDA宣佈將通過一系列方法減少、改進或取代在單克隆抗體療法及其他藥物的研發中動物試驗要求,包括基於AI的毒性計算模型、在實驗室環境中進行的細胞系和類器官毒性測試。2025年計劃啓動試點項目,允許部分藥企在FDA監督下完全跳過動物實驗,全面政策更新預計2026年完成。FDA此項政策將進一步推動AI在新藥研發中的覆蓋,從化學合成環節加速走向臨牀前及臨牀試驗等生物環節,推動創新藥企業加大AI藥物發現平臺投入。再次強調2025年“AI+醫療”將迎來跨越式發展,應重視相關投資機會。
金融界
·
04-16
百誠醫藥:公司已獲得1個1類創新藥 10個2類創新藥的臨牀試驗批准
美港电讯
·
04-15
【研報掘金丨中銀證券:恆瑞醫藥全年業績快速增長,維持“買入”評級】中銀證券研報指出,恆瑞醫藥(600276.SH)24年歸屬上市公司股東的淨利潤為63.37億元,同比增長47.28%,公司保持穩健增長,看好公司的龍頭地位以及創新平台的管線價值,維持“買入”評級。公司全年業績快速增長,主要一方面,集採對公司仿製藥的影響已經逐步消除,公司創新藥開始快速放量;另一方面,公司海外BD也逐步進入收穫期,2024年,公司收到Merck Healthcare 1.6億歐元對外許可首付款以及 KaileraTherapeutics 1.0億美元對外許可首付款等許可合作對價,進一步給公司帶來業績彈性。分季度來看,Q4單季度實現營業收入77.95億元,同比增長34.26%,歸母淨利潤為17.17億元,同比增長107.20%;扣非歸母淨利潤15.62億元,同比增長99.94%,四季度保持快速增長。
金融界
·
04-15
機構看好港股創新藥成長空間,港股創新藥ETF上演V型反彈
银柿财经
·
04-15
恒生醫療指數ETF溢價交易,方舟健客漲超23%,機構:創新藥仍將是醫藥板塊成長主線
21世纪经济报道
·
04-15
國金證券:創新藥將是醫藥板塊成長主線 一季報後帶來左側板塊個股投資機會
智通财经
·
04-15
【映恩生物高開超90% 昨日暗盤迎來大漲】截至發稿,映恩生物(09606.HK)漲91.33%。消息方面,該公司在昨日的暗盤大漲87.1%。根據公開資料,映恩生物是一家專注於新一代抗體偶聯藥物研發的創新生物製藥企業,致力於爲癌症和自身免疫性疾病等患者研發新一代ADC創新藥物。
金融界
·
04-15
新股首日 | 映恩生物-B(09606)首掛上市 早盤高開91.33% 公司為ADC創新藥物研發商
智通财经
·
04-15
大漲超5%,創新藥相關ETF能上車嗎?
市场资讯
·
04-14
一品紅:AR882目前尚未實現上市銷售 未產生銷售收入
美港电讯
·
04-14
【一品紅:AR882目前尚未實現上市銷售 未產生銷售收入】一品紅(300723.SZ)發佈異動,公司合作在研創新藥AR882尚需在國內外開展Ⅲ期臨牀研究並經藥品審評部門審批通過後,方可上市銷售,能否通過監管部門的最終批准、獲批上市及上市時間具有不確定性。AR882目前尚未實現上市銷售,未產生銷售收入,對公司近期業績不會產生重大影響。敬請廣大投資者理性投資,注意風險。
金融界
·
04-14
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/06978/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"06978","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06978\",,,,,undefined,":{"symbol":"06978","market":"HK","secType":"STK","nameCN":"永泰生物-B","latestPrice":4.1,"timestamp":1744877289036,"preClose":3.95,"halted":0,"volume":147000,"delay":0,"floatShares":514584000,"shares":514584000,"eps":-0.386194653854216,"marketStatus":"休市中","change":0.15,"latestTime":"04-17 16:08:09","open":3.94,"high":4.1,"low":3.9,"amount":590200,"amplitude":0.050633,"askPrice":4.1,"askSize":8000,"bidPrice":3.91,"bidSize":4000,"shortable":0,"etf":0,"ttmEps":-0.386194653854216,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1745285400000},"marketStatusCode":7,"adr":0,"listingDate":1594310400000,"exchange":"SEHK","adjPreClose":3.95,"openAndCloseTimeList":[[1744853400000,1744862400000],[1744866000000,1744876800000]],"volumeRatio":0.7469512199676531,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06978\",,,,,undefined,":{"symbol":"06978","floatShares":514584000,"roa":"-17.81%","roe":"-242.61%","lyrEps":-0.386195,"volumeRatio":0.7469512199676531,"shares":514584000,"dividePrice":0,"high":4.1,"amplitude":0.050633,"preClose":3.95,"low":3.9,"week52Low":1.5,"pbRate":"-149.24","week52High":6.15,"institutionHeld":0,"latestPrice":4.1,"committee":-0.333333,"eps":-0.386194653854216,"divideRate":0,"volume":147000,"delay":0,"ttmEps":-0.386194653854216,"open":3.94,"prevYearClose":2.3,"prevWeekClose":3.95,"prevMonthClose":4.45,"prevQuarterClose":4.45,"fiveDayClose":3.65,"twentyDayClose":4.35,"sixtyDayClose":2.58},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06978\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2528061776","title":"阿斯利康(AZN.US)乳腺癌1類創新藥在中國獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2528061776","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528061776?lang=zh_tw&edition=fundamental","pubTime":"2025-04-18 21:14","pubTimestamp":1744982042,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,4月18日,中国国家药监局官网最新公示,批准阿斯利康的1类创新药卡匹色替片上市。该产品已于2023年11月获美国FDA批准上市,用于治疗激素受体阳性、人表皮生长因子受体2阴性的晚期或转移性乳腺癌成年患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1280966.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK4585","LU0889565916.HKD","159992","BK4568","AZN","LU2417539215.USD","LU2456880835.USD","LU2462157665.USD","BK1574","LU0320765992.SGD","LU2236285917.USD","BK4007","LU1829250122.USD","06978","BK4588","LU0109394709.USD"],"gpt_icon":0},{"id":"2528066604","title":"【國家藥監局批准卡匹色替片上市】近日,國家藥品監督管理局批准AstraZeneca UK Limited申報的1類創新藥卡匹色替片(商品名:荃科得(TRUQAP)),該藥適用於聯合氟維司羣用於轉移性階段至少接受過一種內分泌治療後疾病進展,或在輔助治療期間或完成輔助治療後12個月內復發的激素受體(HR)陽性、人表皮生長因子受體2(HER2)陰性且伴有一種或多種PIK3CA/AKT1/PTEN改變的局部晚期或轉移性乳腺癌成人患者。該藥品上市為患者提供了新的治療選擇。","url":"https://stock-news.laohu8.com/highlight/detail?id=2528066604","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528066604?lang=zh_tw&edition=fundamental","pubTime":"2025-04-18 20:21","pubTimestamp":1744978916,"startTime":"0","endTime":"0","summary":"近日,国家药品监督管理局批准AstraZeneca UK Limited申报的1类创新药卡匹色替片(商品名:荃科得(TRUQAP)),该药适用于联合氟维司群用于转移性阶段至少接受过一种内分泌治疗后疾病进展,或在辅助治疗期间或完成辅助治疗后12个月内复发的激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性且伴有一种或多种PIK3CA/AKT1/PTEN改变的局部晚期或转移性乳腺癌成人患者。该药品上市为患者提供了新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/18202149672343.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1574","BK4225","159992","PTEN","BK1161","06978","HR","BK4203","BK4092"],"gpt_icon":0},{"id":"2528874737","title":"武漢人福創新藥物研發中心有限公司藥品申請臨牀試驗默示許可獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2528874737","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528874737?lang=zh_tw&edition=fundamental","pubTime":"2025-04-17 12:16","pubTimestamp":1744863387,"startTime":"0","endTime":"0","summary":"4月17日,据CDE官网消息,武汉人福创新药物研发中心有限公司联合申请药品“HWS116注射液”,获得临床试验默示许可,受理号CXSL2500125。公示信息显示,药品“HWS116注射液”适应症:晚期实体瘤。武汉人福创新药物研发中心有限公司,成立于2020年,位于武汉市,是一家以从事研究和试验发展为主的企业。企业注册资本2000万人民币,实缴资本2000万人民币。通过天眼查大数据分析,武汉人福创新药物研发中心有限公司专利信息132条,此外企业还拥有行政许可3个。主要股东信息显示,武汉人福创新药物研发中心有限公司由人福医药集团股份公司持股100%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/17121649612043.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1576","BK1574","BK1141","BK1161","BK1583","159992","06978","03347"],"gpt_icon":0},{"id":"2528739022","title":"迪哲醫藥18億定增落地,多家機構搶籌入局","url":"https://stock-news.laohu8.com/highlight/detail?id=2528739022","media":"华尔街见闻","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528739022?lang=zh_tw&edition=fundamental","pubTime":"2025-04-17 11:33","pubTimestamp":1744860836,"startTime":"0","endTime":"0","summary":"“科八条”发布以来,再融资获得证监会注册的首家上交所未盈利企业。","market":"hk","thumbnail":"https://wpimg-wscn.awtmt.com/ab479b0a-6970-4f8f-97ad-c2fe242cc086.png","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/ab479b0a-6970-4f8f-97ad-c2fe242cc086.png"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3745376","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3745376","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["BK1161","BK4534","LU1829250122.USD","IE0034235071.USD","BK4585","BK4118","BK4588","UBS","06978","BK1574"],"gpt_icon":0},{"id":"2528358007","title":"恒生醫療指數ETF飄紅,一脈陽光漲超12%,機構:持續看好A股、港股創新藥企出海進程","url":"https://stock-news.laohu8.com/highlight/detail?id=2528358007","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528358007?lang=zh_tw&edition=fundamental","pubTime":"2025-04-17 10:20","pubTimestamp":1744856411,"startTime":"0","endTime":"0","summary":"4月17日,港股早盘开盘后快速拉升,截至发稿,恒生指数、恒生科技指数均涨超1%。热门ETF中,恒生医疗指数ETF早盘震荡走强,截至发稿涨0.88%。恒生医疗指数ETF标的指数为恒生医疗保健指数,该指数旨在反映恒生综合指数里主要经营医疗保健业务成分股公司的表现。国金证券研报称,美国潜在关税威胁对我国创新药影响小。总体来说,在药品各细分领域中,我们预期关税波动对创新药赛道影响较小,持续看好A股、港股创新药企出海进程。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417102602a45bdb9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417102602a45bdb9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06978","BK1219","02522","BK1161","HSTECH"],"gpt_icon":1},{"id":"2528780415","title":"復宏漢霖(02696)CEO朱儁:挖掘出創新藥“未被滿足的需求”,經濟效益將自顯","url":"https://stock-news.laohu8.com/highlight/detail?id=2528780415","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528780415?lang=zh_tw&edition=fundamental","pubTime":"2025-04-17 10:18","pubTimestamp":1744856295,"startTime":"0","endTime":"0","summary":"对于双面优势,在4月15日举办的以“聚·创”为主题的复宏汉霖2025年全球研发日上,其执行董事兼首席执行官朱俊明确表示,管线价值的多维扩展核心在于挖掘“未被满足的需求”,一旦这些需求被发现,经济效益将自然而然地显现。得益于因地制宜的国际化打发,截至目前,复宏汉霖实现与全球100多个市场建立了授权合作网络,其中包括上述的4款产品,它们已经覆盖了50多个国家。天风、招银证券在最新研报中给予复宏汉霖“买入”评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1279913.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","159992","06978","02696","BK1161"],"gpt_icon":0},{"id":"2528910781","title":"國金證券:以BD出海關税風險小 看好創新藥國際化進程","url":"https://stock-news.laohu8.com/highlight/detail?id=2528910781","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528910781?lang=zh_tw&edition=fundamental","pubTime":"2025-04-17 09:17","pubTimestamp":1744852647,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,国金证券发布研报称,坚定看好我国创新药企能够穿越本轮关税周期。总体来说,在药品各细分领域中,该行预期关税波动对创新药赛道影响较小,持续看好A股、港股创新药企出海进程。因此,若相关政策落地、预计对我国创新药赛道潜在影响有限。美国潜在的药品专项关税的首要博弈对象将是欧盟,因此也从侧面反应该专项关税预计对我国的影响有限。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1279880.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0201","BK1574","06978","BK0183","BK0012","159992","600109","BK0188","BK0276","BK1161","BK0028"],"gpt_icon":0},{"id":"2527214391","title":"中證創新藥產業指數下跌0.73%,前十大權重包含復星醫藥等","url":"https://stock-news.laohu8.com/highlight/detail?id=2527214391","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527214391?lang=zh_tw&edition=fundamental","pubTime":"2025-04-16 20:39","pubTimestamp":1744807147,"startTime":"0","endTime":"0","summary":"金融界4月16日消息,A股三大指数收盘涨跌不一,中证创新药产业指数 下跌0.73%,报1625.57点,成交额159.95亿元。数据统计显示,中证创新药产业指数近一个月下跌1.21%,近三个月上涨7.49%,年至今上涨3.17%。据了解,中证创新药产业指数从主营业务涉及创新药研发的上市公司证券中,选取不超过50只最具代表性上市公司证券作为指数样本,以反映创新药产业上市公司证券的整体表现。从中证创新药产业指数持仓样本的行业来看,医药卫生占比100.00%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/16203949599985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","BK0196","BK0012","02196","BK1574","BK1515","159992","BK0188","BK0060","06978","BK0028","BK1191","BK0183","BK0239","BK0175","600196","BK0187","BK0096","BK1593"],"gpt_icon":0},{"id":"2527325671","title":"港股異動 | 同源康醫藥-B(02410)尾盤漲超6% TY-9591入選ASCO本土創新藥企實現技術突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2527325671","media":"智通财经网","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527325671?lang=zh_tw&edition=fundamental","pubTime":"2025-04-16 15:20","pubTimestamp":1744788000,"startTime":"0","endTime":"0","summary":"同源康医药-B尾盘涨超6%,截至发稿,涨5.54%,报57.6港元,成交额4703.9万港元。消息面上,2025年美国临床肿瘤学会年会将于2025年5月30日至6月3日于美国芝加哥举行。同源康医药核心产品TY-9591的最新研究成果也入选2025年美国临床肿瘤学会大会报告。这是TY-9591首次亮相ASCO大会,并荣获口头报告。由于出色的关键II期临床试验结果,TY-9591有望成为全球第一个获批脑转移适应症的三代EGFR抑制剂。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-16/doc-inetiwey0209077.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","06978","159992","09939","BK1574","TY","BK1161","02410","159938"],"gpt_icon":0},{"id":"2527771164","title":"【華泰證券:AI醫療產業趨勢正在加速】華泰證券研報表示,4月10日,美國FDA宣佈將通過一系列方法減少、改進或取代在單克隆抗體療法及其他藥物的研發中動物試驗要求,包括基於AI的毒性計算模型、在實驗室環境中進行的細胞系和類器官毒性測試。2025年計劃啓動試點項目,允許部分藥企在FDA監督下完全跳過動物實驗,全面政策更新預計2026年完成。FDA此項政策將進一步推動AI在新藥研發中的覆蓋,從化學合成環節加速走向臨牀前及臨牀試驗等生物環節,推動創新藥企業加大AI藥物發現平臺投入。再次強調2025年“AI+醫療”將迎來跨越式發展,應重視相關投資機會。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527771164","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527771164?lang=zh_tw&edition=fundamental","pubTime":"2025-04-16 07:54","pubTimestamp":1744761297,"startTime":"0","endTime":"0","summary":"华泰证券研报表示,4月10日,美国FDA宣布将通过一系列方法减少、改进或取代在单克隆抗体疗法及其他药物的研发中动物试验要求,包括基于AI的毒性计算模型、在实验室环境中进行的细胞系和类器官毒性测试。2025年计划启动试点项目,允许部分药企在FDA监督下完全跳过动物实验,全面政策更新预计2026年完成。FDA此项政策将进一步推动AI在新药研发中的覆盖,从化学合成环节加速走向临床前及临床试验等生物环节,推动创新药企业加大AI药物发现平台投入。再次强调2025年“AI+医疗”将迎来跨越式发展,应重视相关投资机会。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/16075449566099.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1564","LU1934453819.USD","LU1064131003.USD","BK1141","BK0276","LU1328615791.USD","LU1979443071.USD","LU1781817850.SGD","BK1583","06886","159891","BK1576","159992","LU2148510915.USD","06978","BK0028","03347","BK1147","601688","BK1161","LU1064130708.USD","LU1580142542.USD","BK0183","BK0012","BK0188","BK1574"],"gpt_icon":0},{"id":"2527134564","title":"百誠醫藥:公司已獲得1個1類創新藥 10個2類創新藥的臨牀試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2527134564","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527134564?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 20:23","pubTimestamp":1744719813,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1141","BK1574","159992","BK1583","BK0216","BK1161","06978","03347","BK1576","301096"],"gpt_icon":0},{"id":"2527434369","title":"【研報掘金丨中銀證券:恆瑞醫藥全年業績快速增長,維持“買入”評級】中銀證券研報指出,恆瑞醫藥(600276.SH)24年歸屬上市公司股東的淨利潤為63.37億元,同比增長47.28%,公司保持穩健增長,看好公司的龍頭地位以及創新平台的管線價值,維持“買入”評級。公司全年業績快速增長,主要一方面,集採對公司仿製藥的影響已經逐步消除,公司創新藥開始快速放量;另一方面,公司海外BD也逐步進入收穫期,2024年,公司收到Merck Healthcare 1.6億歐元對外許可首付款以及 KaileraTherapeutics 1.0億美元對外許可首付款等許可合作對價,進一步給公司帶來業績彈性。分季度來看,Q4單季度實現營業收入77.95億元,同比增長34.26%,歸母淨利潤為17.17億元,同比增長107.20%;扣非歸母淨利潤15.62億元,同比增長99.94%,四季度保持快速增長。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527434369","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527434369?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 13:52","pubTimestamp":1744696347,"startTime":"0","endTime":"0","summary":"中银证券研报指出,恒瑞医药24年归属上市公司股东的净利润为63.37亿元,同比增长47.28%,公司保持稳健增长,看好公司的龙头地位以及创新平台的管线价值,维持“买入”评级。分季度来看,Q4单季度实现营业收入77.95亿元,同比增长34.26%,归母净利润为17.17亿元,同比增长107.20%;扣非归母净利润15.62亿元,同比增长99.94%,四季度保持快速增长。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/15135249542494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159992","601696","06978","600276"],"gpt_icon":0},{"id":"2527481289","title":"機構看好港股創新藥成長空間,港股創新藥ETF上演V型反彈","url":"https://stock-news.laohu8.com/highlight/detail?id=2527481289","media":"银柿财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527481289?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 11:45","pubTimestamp":1744688751,"startTime":"0","endTime":"0","summary":"港股创新药板块高盈利持续消化估值。港股创新药ETF连续10个交易日获得资金净流入。小而美、高弹性:港股创新药ETF跟踪国证港股通创新药指数,创新药企业权重90%为全市场医药主题类指数中最高,有望把握AI赋能创新药研发、国产创新药出海、商业健康保险逐步完善的创新药利好浪潮。综上所述,港股创新药板块具备较高的投资价值,值得投资者重点关注。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/15114549541914.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["06978","BK1574","513120","BK4614","HSTECH","BK1161","159992","YANG"],"gpt_icon":1},{"id":"2527083102","title":"恒生醫療指數ETF溢價交易,方舟健客漲超23%,機構:創新藥仍將是醫藥板塊成長主線","url":"https://stock-news.laohu8.com/highlight/detail?id=2527083102","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527083102?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 10:45","pubTimestamp":1744685109,"startTime":"0","endTime":"0","summary":"相关ETF中,恒生医疗指数ETF截至发稿涨0.17%,溢折率达1.12%,溢价交易明显。成分股中,方舟健客涨超23%,爱康医疗、康方生物、巨子生物等多股跟涨。恒生医疗指数ETF标的指数为恒生医疗保健指数,该指数旨在反映恒生综合指数里主要经营医疗保健业务成分股公司的表现。国金证券认为,医药板块同时具备良好的抗风险能力和成长进攻能力,创新药板块实际地缘政治和关税风险很低,仍将是医药板块成长主线,继续看好港股和A股创新药公司成长空间。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415104805973815cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415104805973815cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","BK1247","BK1161","BK1515","BK1574","09939","06086"],"gpt_icon":0},{"id":"2527108167","title":"國金證券:創新藥將是醫藥板塊成長主線 一季報後帶來左側板塊個股投資機會","url":"https://stock-news.laohu8.com/highlight/detail?id=2527108167","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527108167?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 09:35","pubTimestamp":1744680911,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,国金证券发布研报称,认为医药板块同时具备良好的抗风险能力和成长进攻能力,创新药板块实际地缘政治和关税风险很低,仍将是医药板块成长主线,继续看好港股和A股创新药公司成长空间。一季报后景气度反转和业绩改善也将带来连锁药房、器械、CXO、仿制药、中药、医疗服务等左侧板块的个股投资机会,建议加大投资。药品板块随着中国科技实力的全球认知提升,中国药企创新实力及其成长空间也开始被资本市场重新关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1278639.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0012","BK0028","BK1515","BK1574","BK0276","BK1161","BK0201","159992","06978","09939","600109","159938","BK0188","BK0183"],"gpt_icon":0},{"id":"2527628177","title":"【映恩生物高開超90% 昨日暗盤迎來大漲】截至發稿,映恩生物(09606.HK)漲91.33%。消息方面,該公司在昨日的暗盤大漲87.1%。根據公開資料,映恩生物是一家專注於新一代抗體偶聯藥物研發的創新生物製藥企業,致力於爲癌症和自身免疫性疾病等患者研發新一代ADC創新藥物。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527628177","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527628177?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 09:27","pubTimestamp":1744680474,"startTime":"0","endTime":"0","summary":"截至发稿,映恩生物(09606.HK)涨91.33%。消息方面,该公司在昨日的暗盘大涨87.1%。根据公开资料,映恩生物是一家专注于新一代抗体偶联药物研发的创新生物制药企业,致力于为癌症和自身免疫性疾病等患者研发新一代ADC创新药物。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5297752f2e4ee415e69380642a004984","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/15092749540314.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["09606","BK4080","BK4231","159992","BK1574","ADC","06978","BK1161"],"gpt_icon":0},{"id":"2527177835","title":"新股首日 | 映恩生物-B(09606)首掛上市 早盤高開91.33% 公司為ADC創新藥物研發商","url":"https://stock-news.laohu8.com/highlight/detail?id=2527177835","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527177835?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 09:21","pubTimestamp":1744680097,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,映恩生物-B首挂上市,公告显示,每股定价94.6港元,共发行1733.23万股股份,每手100股,所得款项净额约15.13亿港元。截至发稿,涨91.33%,报181港元,成交额7.82亿港元。公开资料显示,映恩生物于2020年正式运营,是抗体偶联药物领域的全球领跑者。其中多项临床阶段的ADC,在17个国家230多个临床试验中心开展7项全球临床试验,已入组超过2000多名患者,50%患者来自海外。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5297752f2e4ee415e69380642a004984","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1278631.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09606","159992","BK4231","06978","BK4080","BK1161","BK1574","ADC"],"gpt_icon":1},{"id":"2527119526","title":"大漲超5%,創新藥相關ETF能上車嗎?","url":"https://stock-news.laohu8.com/highlight/detail?id=2527119526","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527119526?lang=zh_tw&edition=fundamental","pubTime":"2025-04-14 22:34","pubTimestamp":1744641240,"startTime":"0","endTime":"0","summary":" 4月14日,A股及港股创新药板块迎来上涨。 A股2只医药股当天收获“20CM”涨停,多只医药股大涨。在板块的带动下,多只港股创新药ETF涨幅居前,单日最高涨幅达6.46%,多只创新药ETF收获5%以上的涨幅。 数据显示,近几个交易日,港股创新药ETF连续获得资金净流入,成为继沪深300、上证50等宽基ETF,黄金ETF,科技、军工等主题ETF之后,又一类被资金关注的ETF产品。 截至4月14日收盘,创新药相关ETF、黄金股ETF领涨全市场ETF。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/roll/2025-04-14/doc-inetcywn9180240.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159992","06978","BK4585","BK4550","BK4588","FDN","BK1161","BK1574"],"gpt_icon":0},{"id":"2527163542","title":"一品紅:AR882目前尚未實現上市銷售 未產生銷售收入","url":"https://stock-news.laohu8.com/highlight/detail?id=2527163542","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527163542?lang=zh_tw&edition=fundamental","pubTime":"2025-04-14 20:44","pubTimestamp":1744634670,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["300723","BK1161","06978","BK0239","BK1574","159992"],"gpt_icon":0},{"id":"2527690163","title":"【一品紅:AR882目前尚未實現上市銷售 未產生銷售收入】一品紅(300723.SZ)發佈異動,公司合作在研創新藥AR882尚需在國內外開展Ⅲ期臨牀研究並經藥品審評部門審批通過後,方可上市銷售,能否通過監管部門的最終批准、獲批上市及上市時間具有不確定性。AR882目前尚未實現上市銷售,未產生銷售收入,對公司近期業績不會產生重大影響。敬請廣大投資者理性投資,注意風險。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527690163","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527690163?lang=zh_tw&edition=fundamental","pubTime":"2025-04-14 20:42","pubTimestamp":1744634526,"startTime":"0","endTime":"0","summary":"一品红(300723.SZ)发布异动,公司合作在研创新药AR882尚需在国内外开展Ⅲ期临床研究并经药品审评部门审批通过后,方可上市销售,能否通过监管部门的最终批准、获批上市及上市时间具有不确定性。AR882目前尚未实现上市销售,未产生销售收入,对公司近期业绩不会产生重大影响。敬请广大投资者理性投资,注意风险。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/14204249532143.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","159992","300723","06978","BK1574","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06978\",params:#limit:5,,,undefined,":[{"date":"2025-03-31","symbol":"06978","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743384600000,"name":null,"time":"盤後","dateTimestamp":1743350400000,"actualEps":null},{"market":"HK","date":"2024-08-23","symbol":"06978","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1724342400000,"reportTimeType":"post","actualEps":null},{"date":"2024-03-28","symbol":"06978","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711589400000,"name":null,"time":"","dateTimestamp":1711555200000,"actualEps":null},{"date":"2023-08-25","symbol":"06978","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692927000000,"name":null,"time":"","dateTimestamp":1692892800000,"actualEps":null},{"date":"2023-03-24","symbol":"06978","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1679621400000,"name":null,"time":"","dateTimestamp":1679587200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06978\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06978\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06978\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06978","date":"2025-04-17","current":-10.624425,"percent":0.333625,"low":-64.250755,"twenty":-18.610485,"median":-6.66693,"eighty":-5.195431,"high":-2.352098,"avg":-11.487293,"sd":9.815477,"marketCap":2109794400},"quantilePoints":[{"date":"2020-07-10","current":-64.250755,"twenty":-56.823009,"median":-45.68139,"eighty":-45.643072,"marketCap":7740000000},{"date":"2020-07-17","current":-47.738664,"twenty":-62.543691,"median":-56.093651,"eighty":-46.5043,"marketCap":5760000000},{"date":"2020-07-24","current":-48.758304,"twenty":-60.681293,"median":-51.911483,"eighty":-48.14652,"marketCap":5860000000},{"date":"2020-07-31","current":-44.255057,"twenty":-57.133865,"median":-50.06671,"eighty":-45.807284,"marketCap":5350000000},{"date":"2020-08-07","current":-51.874862,"twenty":-53.348464,"median":-49.949829,"eighty":-45.709389,"marketCap":6277924800},{"date":"2020-08-14","current":-46.400908,"twenty":-52.782782,"median":-48.248484,"eighty":-45.849283,"marketCap":5629548960},{"date":"2020-08-21","current":-49.822461,"twenty":-52.432957,"median":-47.738664,"eighty":-46.047362,"marketCap":6072091200},{"date":"2020-08-28","current":-22.401434,"twenty":-51.896835,"median":-47.599585,"eighty":-45.930781,"marketCap":5876549280},{"date":"2020-09-04","current":-21.231016,"twenty":-51.819667,"median":-47.268268,"eighty":-45.566352,"marketCap":5588382240},{"date":"2020-09-11","current":-20.505254,"twenty":-51.592171,"median":-46.80611,"eighty":-22.36802,"marketCap":5403132000},{"date":"2020-09-18","current":-20.695196,"twenty":-50.805001,"median":-46.400908,"eighty":-21.283108,"marketCap":5506048800},{"date":"2020-09-25","current":-20.237053,"twenty":-49.898882,"median":-46.060171,"eighty":-20.625315,"marketCap":5341381920},{"date":"2020-09-30","current":-20.412634,"twenty":-49.822461,"median":-45.887219,"eighty":-20.503463,"marketCap":5413423680},{"date":"2020-10-09","current":-19.204759,"twenty":-49.788513,"median":-45.649459,"eighty":-20.430478,"marketCap":5166423360},{"date":"2020-10-16","current":-19.250915,"twenty":-48.758304,"median":-45.299714,"eighty":-20.339309,"marketCap":5176715040},{"date":"2020-10-23","current":-19.087374,"twenty":-48.307178,"median":-22.373589,"eighty":-19.790209,"marketCap":5140694160},{"date":"2020-10-30","current":-17.002143,"twenty":-47.973716,"median":-21.730857,"eighty":-19.650496,"marketCap":4579797600},{"date":"2020-11-06","current":-15.106198,"twenty":-47.769001,"median":-21.231016,"eighty":-19.330222,"marketCap":4116672000},{"date":"2020-11-13","current":-15.338789,"twenty":-47.732782,"median":-20.712404,"eighty":-19.183908,"marketCap":4183567920},{"date":"2020-11-20","current":-17.586861,"twenty":-47.520548,"median":-20.505254,"eighty":-18.994861,"marketCap":4826797920},{"date":"2020-11-27","current":-18.229444,"twenty":-47.402905,"median":-20.494732,"eighty":-18.749627,"marketCap":4991464800},{"date":"2020-12-04","current":-18.565689,"twenty":-47.291948,"median":-20.430478,"eighty":-18.414649,"marketCap":5120110800},{"date":"2020-12-11","current":-18.161329,"twenty":-47.217671,"median":-20.396179,"eighty":-18.215821,"marketCap":4996610640},{"date":"2020-12-18","current":-18.356014,"twenty":-47.075208,"median":-20.291507,"eighty":-18.119245,"marketCap":5058360720},{"date":"2020-12-24","current":-18.878072,"twenty":-46.758781,"median":-19.867869,"eighty":-18.148113,"marketCap":5207590080},{"date":"2020-12-31","current":-20.809585,"twenty":-46.541923,"median":-20.237053,"eighty":-18.175196,"marketCap":5742757440},{"date":"2021-01-08","current":-19.219362,"twenty":-20.610256,"median":-19.660021,"eighty":-19.090248,"marketCap":5351673600},{"date":"2021-01-15","current":-21.800557,"twenty":-20.610256,"median":-19.166958,"eighty":-18.860728,"marketCap":6061799520},{"date":"2021-01-22","current":-23.624128,"twenty":-21.60053,"median":-20.298412,"eighty":-18.9843,"marketCap":6566091840},{"date":"2021-01-29","current":-21.006586,"twenty":-21.929729,"median":-20.673555,"eighty":-19.049288,"marketCap":5886840960},{"date":"2021-02-05","current":-21.613468,"twenty":-21.850772,"median":-20.809585,"eighty":-19.090248,"marketCap":6020632800},{"date":"2021-02-11","current":-21.988352,"twenty":-21.931546,"median":-21.243458,"eighty":-19.156477,"marketCap":6133841280},{"date":"2021-02-19","current":-21.573115,"twenty":-21.977718,"median":-21.371725,"eighty":-19.307494,"marketCap":6020632800},{"date":"2021-02-26","current":-29.566681,"twenty":-22.425808,"median":-21.481795,"eighty":-19.787699,"marketCap":8233344000},{"date":"2021-03-05","current":-30.567268,"twenty":-23.553882,"median":-21.613468,"eighty":-20.341848,"marketCap":8490636000},{"date":"2021-03-12","current":-30.361062,"twenty":-28.458177,"median":-21.838684,"eighty":-20.531445,"marketCap":8418594240},{"date":"2021-03-19","current":-31.744925,"twenty":-29.508969,"median":-21.93518,"eighty":-20.626337,"marketCap":8799386400},{"date":"2021-03-26","current":-16.974873,"twenty":-30.348923,"median":-21.961766,"eighty":-20.531445,"marketCap":8850844800},{"date":"2021-04-01","current":-16.623698,"twenty":-30.300365,"median":-21.901454,"eighty":-19.219362,"marketCap":8645011200},{"date":"2021-04-09","current":-16.666073,"twenty":-29.860155,"median":-21.800557,"eighty":-19.049288,"marketCap":8686177920},{"date":"2021-04-16","current":-16.544192,"twenty":-29.393546,"median":-21.593291,"eighty":-18.570217,"marketCap":8655302880},{"date":"2021-04-23","current":-23.096804,"twenty":-29.186763,"median":-21.700237,"eighty":-18.570217,"marketCap":9262512000},{"date":"2021-04-30","current":-22.133022,"twenty":-28.911798,"median":-21.901454,"eighty":-18.739985,"marketCap":8912594880},{"date":"2021-05-07","current":-21.711211,"twenty":-28.729562,"median":-21.93518,"eighty":-18.860728,"marketCap":8799386400},{"date":"2021-05-14","current":-22.1065,"twenty":-27.968112,"median":-21.961766,"eighty":-18.9843,"marketCap":8953761600},{"date":"2021-05-21","current":-21.744771,"twenty":-26.901976,"median":-21.924705,"eighty":-19.047039,"marketCap":8809678080},{"date":"2021-05-28","current":-22.236938,"twenty":-25.888557,"median":-21.926095,"eighty":-19.078094,"marketCap":9097845120},{"date":"2021-06-04","current":-27.42308,"twenty":-26.859589,"median":-22.019765,"eighty":-19.156477,"marketCap":11166472800},{"date":"2021-06-11","current":-25.529339,"twenty":-26.221965,"median":-22.07768,"eighty":-19.395626,"marketCap":10394596800},{"date":"2021-06-18","current":-23.546505,"twenty":-26.036969,"median":-22.1065,"eighty":-19.787699,"marketCap":9509512320},{"date":"2021-06-25","current":-23.280842,"twenty":-25.974137,"median":-22.212035,"eighty":-20.341848,"marketCap":9396303840},{"date":"2021-07-02","current":-23.091699,"twenty":-25.737198,"median":-22.24035,"eighty":-20.515592,"marketCap":9303678720},{"date":"2021-07-09","current":-22.50119,"twenty":-25.664591,"median":-22.284794,"eighty":-20.594858,"marketCap":9056678400},{"date":"2021-07-16","current":-25.26322,"twenty":-25.529339,"median":-22.40085,"eighty":-20.752251,"marketCap":10168179840},{"date":"2021-07-23","current":-21.762215,"twenty":-25.475548,"median":-22.402001,"eighty":-20.779118,"marketCap":8758219680},{"date":"2021-07-30","current":-21.893237,"twenty":-25.382377,"median":-22.368475,"eighty":-20.809585,"marketCap":8840553120},{"date":"2021-08-06","current":-21.077581,"twenty":-25.26322,"median":-22.255781,"eighty":-21.006586,"marketCap":8490636000},{"date":"2021-08-13","current":-22.069454,"twenty":-24.932865,"median":-22.224809,"eighty":-21.077581,"marketCap":8902303200},{"date":"2021-08-20","current":-19.93175,"twenty":-24.502087,"median":-22.15655,"eighty":-20.881216,"marketCap":8017218720},{"date":"2021-08-27","current":-16.592623,"twenty":-24.496045,"median":-22.093152,"eighty":-20.700698,"marketCap":8233344000},{"date":"2021-09-03","current":-16.710278,"twenty":-24.399025,"median":-22.069454,"eighty":-19.93175,"marketCap":8295094080},{"date":"2021-09-10","current":-16.41926,"twenty":-24.289094,"median":-22.019765,"eighty":-19.053788,"marketCap":8171593920},{"date":"2021-09-17","current":-16.63389,"twenty":-23.930962,"median":-21.93518,"eighty":-18.640349,"marketCap":8253927360},{"date":"2021-09-24","current":-16.190849,"twenty":-23.888488,"median":-21.923314,"eighty":-17.240757,"marketCap":8037802080},{"date":"2021-09-30","current":-16.116184,"twenty":-23.827822,"median":-21.883844,"eighty":-17.072475,"marketCap":8027510400},{"date":"2021-10-08","current":-16.385535,"twenty":-23.738966,"median":-21.828724,"eighty":-16.950395,"marketCap":8161302240},{"date":"2021-10-15","current":-16.436249,"twenty":-23.670834,"median":-21.799775,"eighty":-16.841587,"marketCap":8192177280},{"date":"2021-10-22","current":-16.872622,"twenty":-23.600968,"median":-21.770736,"eighty":-16.756837,"marketCap":8470052640},{"date":"2021-10-29","current":-16.647267,"twenty":-23.558338,"median":-21.727991,"eighty":-16.721383,"marketCap":8336260800},{"date":"2021-11-05","current":-16.00433,"twenty":-23.53397,"median":-21.699338,"eighty":-16.703821,"marketCap":8027510400},{"date":"2021-11-12","current":-15.999919,"twenty":-23.508496,"median":-21.593291,"eighty":-16.647891,"marketCap":8058385440},{"date":"2021-11-19","current":-15.961202,"twenty":-23.494679,"median":-21.539814,"eighty":-16.605053,"marketCap":8027510400},{"date":"2021-11-26","current":-14.728703,"twenty":-23.464887,"median":-21.455004,"eighty":-16.570109,"marketCap":7410009600},{"date":"2021-12-03","current":-15.314086,"twenty":-23.420591,"median":-21.393364,"eighty":-16.537545,"marketCap":7718760000},{"date":"2021-12-10","current":-15.593741,"twenty":-23.36801,"median":-21.328159,"eighty":-16.486789,"marketCap":7873135200},{"date":"2021-12-17","current":-15.359751,"twenty":-23.296865,"median":-21.180222,"eighty":-16.397318,"marketCap":7749635040},{"date":"2021-12-24","current":-16.058347,"twenty":-23.277664,"median":-21.092226,"eighty":-16.358332,"marketCap":8109843840},{"date":"2021-12-31","current":-17.12155,"twenty":-23.255297,"median":-21.019793,"eighty":-16.371489,"marketCap":8665594560},{"date":"2022-01-07","current":-17.14598,"twenty":-21.956449,"median":-17.811572,"eighty":-16.369371,"marketCap":8645011200},{"date":"2022-01-14","current":-8.350684,"twenty":-21.929729,"median":-17.693567,"eighty":-16.226058,"marketCap":4219588800},{"date":"2022-01-21","current":-9.13429,"twenty":-21.896525,"median":-17.637501,"eighty":-16.186957,"marketCap":4626110160},{"date":"2022-01-28","current":-7.181483,"twenty":-21.838166,"median":-17.586861,"eighty":-16.14691,"marketCap":3627817200},{"date":"2022-02-04","current":-7.592665,"twenty":-21.812402,"median":-17.579991,"eighty":-16.139067,"marketCap":3833650800},{"date":"2022-02-11","current":-6.926418,"twenty":-21.800557,"median":-17.495461,"eighty":-16.11667,"marketCap":3504317040},{"date":"2022-02-18","current":-6.983658,"twenty":-21.700237,"median":-17.332121,"eighty":-16.096504,"marketCap":3550629600},{"date":"2022-02-25","current":-6.502051,"twenty":-21.649313,"median":-17.260861,"eighty":-16.065911,"marketCap":3313920960},{"date":"2022-03-04","current":-5.934382,"twenty":-21.613468,"median":-17.205212,"eighty":-15.999919,"marketCap":3025753920},{"date":"2022-03-11","current":-5.559262,"twenty":-21.573115,"median":-17.186549,"eighty":-15.962686,"marketCap":2830212000},{"date":"2022-03-18","current":-6.088927,"twenty":-21.496411,"median":-17.163649,"eighty":-15.922667,"marketCap":3087504000},{"date":"2022-03-25","current":-5.77409,"twenty":-21.467179,"median":-17.159376,"eighty":-15.682097,"marketCap":2927982960},{"date":"2022-04-01","current":-6.114952,"twenty":-21.361756,"median":-17.134014,"eighty":-15.63502,"marketCap":2675836800},{"date":"2022-04-08","current":-6.212187,"twenty":-21.361347,"median":-17.127609,"eighty":-15.589598,"marketCap":2711857680},{"date":"2022-04-14","current":-6.419698,"twenty":-21.283108,"median":-17.083063,"eighty":-15.475686,"marketCap":2799336960},{"date":"2022-04-22","current":-6.307715,"twenty":-21.141244,"median":-17.056593,"eighty":-15.397224,"marketCap":2696420160},{"date":"2022-04-29","current":-6.484304,"twenty":-20.991418,"median":-17.033724,"eighty":-15.323967,"marketCap":2727295200},{"date":"2022-05-06","current":-6.168507,"twenty":-20.938747,"median":-17.01036,"eighty":-15.154258,"marketCap":2572920000},{"date":"2022-05-13","current":-6.218079,"twenty":-20.819072,"median":-16.993375,"eighty":-14.728703,"marketCap":2547190800},{"date":"2022-05-20","current":-6.590396,"twenty":-20.809585,"median":-16.923698,"eighty":-13.625224,"marketCap":2737586880},{"date":"2022-05-27","current":-6.348143,"twenty":-20.80027,"median":-16.893842,"eighty":-10.04096,"marketCap":2634670080},{"date":"2022-06-02","current":-6.412915,"twenty":-20.761855,"median":-16.882194,"eighty":-9.006929,"marketCap":2675836800},{"date":"2022-06-10","current":-6.803968,"twenty":-20.734139,"median":-16.872622,"eighty":-8.222479,"marketCap":2819920320},{"date":"2022-06-17","current":-6.276962,"twenty":-20.702079,"median":-16.828518,"eighty":-7.515565,"marketCap":2598649200},{"date":"2022-06-24","current":-6.796805,"twenty":-20.614926,"median":-16.781481,"eighty":-7.349566,"marketCap":2825066160},{"date":"2022-06-30","current":-6.6101,"twenty":-20.585179,"median":-16.763348,"eighty":-7.107723,"marketCap":2742732720},{"date":"2022-07-08","current":-6.380302,"twenty":-20.540846,"median":-16.747681,"eighty":-6.96841,"marketCap":2650107600},{"date":"2022-07-15","current":-6.314937,"twenty":-20.509389,"median":-16.723273,"eighty":-6.8399,"marketCap":2598649200},{"date":"2022-07-22","current":-6.348286,"twenty":-20.504179,"median":-16.707567,"eighty":-6.790273,"marketCap":2614086720},{"date":"2022-07-29","current":-6.178294,"twenty":-20.500085,"median":-16.703306,"eighty":-6.730932,"marketCap":2547190800},{"date":"2022-08-05","current":-5.981345,"twenty":-20.494111,"median":-16.675219,"eighty":-6.695285,"marketCap":2459711520},{"date":"2022-08-29","current":-5.113803,"twenty":-20.492871,"median":-16.673253,"eighty":-6.680019,"marketCap":2017169280},{"date":"2022-09-16","current":-5.084123,"twenty":-20.49163,"median":-16.67077,"eighty":-6.672352,"marketCap":1981148400},{"date":"2022-09-23","current":-5.852612,"twenty":-20.464962,"median":-16.666073,"eighty":-6.668228,"marketCap":2253877920},{"date":"2022-09-30","current":-5.444046,"twenty":-20.43716,"median":-16.648046,"eighty":-6.590256,"marketCap":2084065200},{"date":"2022-10-07","current":-5.761223,"twenty":-20.424936,"median":-16.643424,"eighty":-6.581701,"marketCap":2207565360},{"date":"2022-10-14","current":-5.428912,"twenty":-20.415028,"median":-16.626828,"eighty":-6.505791,"marketCap":2063481840},{"date":"2022-10-21","current":-6.2915,"twenty":-20.39947,"median":-16.596895,"eighty":-6.469533,"marketCap":2377378080},{"date":"2022-10-28","current":-7.926499,"twenty":-20.363558,"median":-16.584893,"eighty":-6.489119,"marketCap":2989733040},{"date":"2022-11-04","current":-7.276635,"twenty":-20.320188,"median":-16.570621,"eighty":-6.498626,"marketCap":2717003520},{"date":"2022-11-11","current":-6.780144,"twenty":-20.269725,"median":-16.555426,"eighty":-6.502259,"marketCap":2562628320},{"date":"2022-11-18","current":-6.842295,"twenty":-20.10465,"median":-16.538652,"eighty":-6.505791,"marketCap":2598649200},{"date":"2022-11-25","current":-6.553131,"twenty":-19.890775,"median":-16.5127,"eighty":-6.505791,"marketCap":2485440720},{"date":"2022-12-02","current":-6.843006,"twenty":-19.836805,"median":-16.478086,"eighty":-6.51116,"marketCap":2624378400},{"date":"2022-12-09","current":-6.803045,"twenty":-19.788807,"median":-16.41926,"eighty":-6.51723,"marketCap":2639815920},{"date":"2022-12-16","current":-6.485221,"twenty":-19.786705,"median":-16.405472,"eighty":-6.511968,"marketCap":2511169920},{"date":"2022-12-23","current":-6.289566,"twenty":-19.773275,"median":-16.382942,"eighty":-6.496342,"marketCap":2439128160},{"date":"2022-12-30","current":-6.128582,"twenty":-19.736764,"median":-16.374442,"eighty":-6.478249,"marketCap":2382523920},{"date":"2023-01-06","current":-6.762617,"twenty":-19.699286,"median":-16.360011,"eighty":-6.451631,"marketCap":2665545120},{"date":"2023-01-13","current":-6.455628,"twenty":-19.639567,"median":-16.258149,"eighty":-6.446151,"marketCap":2598649200},{"date":"2023-01-20","current":-6.961646,"twenty":-19.465265,"median":-16.212448,"eighty":-6.448135,"marketCap":2794191120},{"date":"2023-01-27","current":-7.061283,"twenty":-19.436768,"median":-16.195153,"eighty":-6.451882,"marketCap":2830212000},{"date":"2023-02-03","current":-9.839934,"twenty":-19.404982,"median":-16.172019,"eighty":-6.458062,"marketCap":3982880160},{"date":"2023-02-10","current":-10.726386,"twenty":-19.382998,"median":-16.150822,"eighty":-6.463477,"marketCap":4312213920},{"date":"2023-02-17","current":-9.129546,"twenty":-19.353207,"median":-16.139067,"eighty":-6.475221,"marketCap":3627817200},{"date":"2023-02-24","current":-8.28312,"twenty":-19.347831,"median":-16.130405,"eighty":-6.484671,"marketCap":3267608400},{"date":"2023-03-03","current":-8.207784,"twenty":-19.335434,"median":-16.116427,"eighty":-6.487445,"marketCap":3236733360},{"date":"2023-03-10","current":-7.690394,"twenty":-7.764012,"median":-7.736405,"eighty":-7.708798,"marketCap":3010316400},{"date":"2023-03-17","current":-6.744359,"twenty":-22.051177,"median":-16.233716,"eighty":-6.525123,"marketCap":2665545120},{"date":"2023-03-24","current":-6.255894,"twenty":-21.988352,"median":-16.202636,"eighty":-6.510622,"marketCap":2500878240},{"date":"2023-03-31","current":-6.371908,"twenty":-21.973081,"median":-16.181118,"eighty":-6.49728,"marketCap":2315628000},{"date":"2023-04-06","current":-6.347683,"twenty":-21.95034,"median":-16.15844,"eighty":-6.484854,"marketCap":2305336320},{"date":"2023-04-14","current":-6.666985,"twenty":-21.931546,"median":-16.139962,"eighty":-6.475221,"marketCap":2423690640},{"date":"2023-04-21","current":-5.608248,"twenty":-21.924983,"median":-16.127786,"eighty":-6.450008,"marketCap":2037752640},{"date":"2023-04-27","current":-5.307876,"twenty":-21.917299,"median":-16.116169,"eighty":-6.422838,"marketCap":1914252480},{"date":"2023-05-05","current":-5.327677,"twenty":-21.893237,"median":-16.096504,"eighty":-6.381168,"marketCap":1924544160},{"date":"2023-05-12","current":-5.063397,"twenty":-21.883844,"median":-16.067785,"eighty":-6.37328,"marketCap":1816481520},{"date":"2023-05-19","current":-5.193805,"twenty":-21.876812,"median":-16.00433,"eighty":-6.352372,"marketCap":1837064880},{"date":"2023-05-25","current":-5.332135,"twenty":-21.852816,"median":-15.995025,"eighty":-6.349951,"marketCap":1878231600},{"date":"2023-06-02","current":-6.713499,"twenty":-21.819285,"median":-15.966218,"eighty":-6.347731,"marketCap":2356794720},{"date":"2023-06-09","current":-6.972749,"twenty":-21.811339,"median":-15.961899,"eighty":-6.347983,"marketCap":2444274000},{"date":"2023-06-16","current":-7.006304,"twenty":-21.804587,"median":-15.922667,"eighty":-6.348229,"marketCap":2444274000},{"date":"2023-06-23","current":-6.822262,"twenty":-21.799931,"median":-15.776346,"eighty":-6.349118,"marketCap":2367086400},{"date":"2023-06-30","current":-6.974336,"twenty":-21.790644,"median":-15.676454,"eighty":-6.3482,"marketCap":2397961440},{"date":"2023-07-07","current":-6.29817,"twenty":-21.775166,"median":-15.63502,"eighty":-6.347707,"marketCap":2161252800},{"date":"2023-07-14","current":-6.329319,"twenty":-21.767328,"median":-15.592936,"eighty":-6.334724,"marketCap":2202419520},{"date":"2023-07-21","current":-6.240015,"twenty":-21.755237,"median":-15.562362,"eighty":-6.327514,"marketCap":2161252800},{"date":"2023-07-28","current":-6.216955,"twenty":-21.731347,"median":-15.460361,"eighty":-6.326905,"marketCap":2150961120},{"date":"2023-08-04","current":-5.879972,"twenty":-21.706821,"median":-15.391985,"eighty":-6.313485,"marketCap":2037752640},{"date":"2023-08-11","current":-5.540043,"twenty":-21.699877,"median":-15.339202,"eighty":-6.301988,"marketCap":1909106640},{"date":"2023-08-18","current":-6.226733,"twenty":-21.679328,"median":-15.220043,"eighty":-6.284775,"marketCap":2130377760},{"date":"2023-08-25","current":-6.614518,"twenty":-21.644836,"median":-15.059295,"eighty":-6.284775,"marketCap":2264169600},{"date":"2023-09-01","current":-7.725483,"twenty":-21.628259,"median":-14.681328,"eighty":-6.29034,"marketCap":2470003200},{"date":"2023-09-08","current":-7.198629,"twenty":-21.597327,"median":-13.725418,"eighty":-6.292382,"marketCap":2274461280},{"date":"2023-09-15","current":-6.820019,"twenty":-21.572504,"median":-12.512969,"eighty":-6.295491,"marketCap":2171544480},{"date":"2023-09-22","current":-6.444165,"twenty":-21.558878,"median":-10.847986,"eighty":-6.301988,"marketCap":2042898480},{"date":"2023-09-29","current":-6.465541,"twenty":-21.522453,"median":-10.161296,"eighty":-6.308461,"marketCap":2053190160},{"date":"2023-10-06","current":-6.760456,"twenty":-21.490565,"median":-10.027457,"eighty":-6.309909,"marketCap":2145815280},{"date":"2023-10-13","current":-6.656915,"twenty":-21.462309,"median":-9.622435,"eighty":-6.311486,"marketCap":2109794400},{"date":"2023-10-20","current":-6.488313,"twenty":-21.435817,"median":-9.283976,"eighty":-6.309909,"marketCap":2053190160},{"date":"2023-10-27","current":-6.653781,"twenty":-21.407775,"median":-9.207244,"eighty":-6.309579,"marketCap":2104648560},{"date":"2023-11-03","current":-6.457682,"twenty":-21.393364,"median":-9.131918,"eighty":-6.311228,"marketCap":2048044320},{"date":"2023-11-10","current":-6.296744,"twenty":-21.371725,"median":-8.987512,"eighty":-6.30637,"marketCap":1996585920},{"date":"2023-11-17","current":-5.83837,"twenty":-21.361756,"median":-8.822135,"eighty":-6.293705,"marketCap":1867939920},{"date":"2023-11-24","current":-6.07784,"twenty":-21.361245,"median":-8.37886,"eighty":-6.289122,"marketCap":1960565040},{"date":"2023-12-01","current":-6.211607,"twenty":-21.294561,"median":-8.29826,"eighty":-6.281581,"marketCap":2012023440},{"date":"2023-12-08","current":-6.603685,"twenty":-21.243458,"median":-8.207784,"eighty":-6.281581,"marketCap":2130377760},{"date":"2023-12-15","current":-6.502333,"twenty":-21.231016,"median":-7.870206,"eighty":-6.283417,"marketCap":2109794400},{"date":"2023-12-22","current":-6.712989,"twenty":-21.180222,"median":-7.725483,"eighty":-6.283417,"marketCap":2176690320},{"date":"2023-12-29","current":-7.892891,"twenty":-21.142972,"median":-7.725353,"eighty":-6.284458,"marketCap":2572920000},{"date":"2024-01-05","current":-7.154057,"twenty":-21.113632,"median":-7.718007,"eighty":-6.28674,"marketCap":2315628000},{"date":"2024-01-12","current":-6.896019,"twenty":-21.095156,"median":-7.690394,"eighty":-6.2893,"marketCap":2233294560},{"date":"2024-01-19","current":-7.128262,"twenty":-21.057905,"median":-7.605247,"eighty":-6.290246,"marketCap":2305336320},{"date":"2024-01-26","current":-6.40536,"twenty":-21.021512,"median":-7.547338,"eighty":-6.291359,"marketCap":2063481840},{"date":"2024-02-02","current":-6.413537,"twenty":-21.009352,"median":-7.52195,"eighty":-6.292382,"marketCap":2063481840},{"date":"2024-02-09","current":-6.000136,"twenty":-20.956438,"median":-7.433604,"eighty":-6.290246,"marketCap":1939981680},{"date":"2024-02-16","current":-6.587584,"twenty":-20.881216,"median":-7.407958,"eighty":-6.291265,"marketCap":2130377760},{"date":"2024-02-23","current":-6.254579,"twenty":-20.819072,"median":-7.377662,"eighty":-6.289122,"marketCap":2012023440},{"date":"2024-03-01","current":-6.154762,"twenty":-20.809585,"median":-7.316378,"eighty":-6.283417,"marketCap":1981148400},{"date":"2024-03-08","current":-5.704607,"twenty":-20.779118,"median":-7.287937,"eighty":-6.277155,"marketCap":1837064880},{"date":"2024-03-15","current":-5.949562,"twenty":-20.752251,"median":-7.261991,"eighty":-6.275765,"marketCap":1914252480},{"date":"2024-03-22","current":-5.971017,"twenty":-20.729611,"median":-7.245567,"eighty":-6.27279,"marketCap":1919398320},{"date":"2024-03-28","current":-5.990176,"twenty":-20.706481,"median":-7.223792,"eighty":-6.255939,"marketCap":1919398320},{"date":"2024-04-05","current":-5.19787,"twenty":-20.698497,"median":-7.192341,"eighty":-6.251955,"marketCap":1883377440},{"date":"2024-04-12","current":-4.797495,"twenty":-20.655061,"median":-7.181144,"eighty":-6.240375,"marketCap":1739293920},{"date":"2024-04-19","current":-4.901036,"twenty":-20.588406,"median":-7.149983,"eighty":-6.234809,"marketCap":1775314800},{"date":"2024-04-26","current":-4.707958,"twenty":-20.553473,"median":-7.119148,"eighty":-6.226961,"marketCap":1703273040},{"date":"2024-05-03","current":-4.882014,"twenty":-20.513524,"median":-7.061283,"eighty":-6.216609,"marketCap":1765023120},{"date":"2024-05-10","current":-4.813653,"twenty":-20.504896,"median":-7.045369,"eighty":-6.205043,"marketCap":1744439760},{"date":"2024-05-17","current":-4.55054,"twenty":-20.503463,"median":-7.034104,"eighty":-6.193894,"marketCap":1646668800},{"date":"2024-05-24","current":-4.361414,"twenty":-20.497833,"median":-7.013517,"eighty":-6.179577,"marketCap":1574627040},{"date":"2024-05-31","current":-4.428172,"twenty":-20.49163,"median":-6.992331,"eighty":-6.168507,"marketCap":1600356240},{"date":"2024-06-07","current":-4.134291,"twenty":-20.447184,"median":-6.974577,"eighty":-6.157971,"marketCap":1492293600},{"date":"2024-06-14","current":-4.708853,"twenty":-20.433819,"median":-6.973449,"eighty":-6.153581,"marketCap":1698127200},{"date":"2024-06-21","current":-4.475645,"twenty":-20.419395,"median":-6.960339,"eighty":-6.135334,"marketCap":1610647920},{"date":"2024-06-28","current":-5.507472,"twenty":-20.413432,"median":-6.937603,"eighty":-6.129985,"marketCap":1981148400},{"date":"2024-07-05","current":-4.993572,"twenty":-20.392888,"median":-6.919207,"eighty":-6.108242,"marketCap":1795898160},{"date":"2024-07-12","current":-4.529055,"twenty":-20.355475,"median":-6.910108,"eighty":-6.077338,"marketCap":1631231280},{"date":"2024-07-19","current":-4.714702,"twenty":-20.314771,"median":-6.896019,"eighty":-6.059896,"marketCap":1698127200},{"date":"2024-07-26","current":-3.857439,"twenty":-20.294269,"median":-6.86808,"eighty":-6.039846,"marketCap":1394522640},{"date":"2024-08-02","current":-4.272717,"twenty":-20.258835,"median":-6.851181,"eighty":-6.018172,"marketCap":1543752000},{"date":"2024-08-09","current":-4.230281,"twenty":-20.053871,"median":-6.84265,"eighty":-5.99701,"marketCap":1538606160},{"date":"2024-08-16","current":-4.412491,"twenty":-19.893421,"median":-6.837336,"eighty":-5.975464,"marketCap":1605502080},{"date":"2024-08-23","current":-4.408003,"twenty":-19.821273,"median":-6.82237,"eighty":-5.952935,"marketCap":1610647920},{"date":"2024-08-30","current":-4.468443,"twenty":-19.788107,"median":-6.817713,"eighty":-5.935167,"marketCap":1518022800},{"date":"2024-09-06","current":-4.314892,"twenty":-19.778647,"median":-6.806826,"eighty":-5.927141,"marketCap":1466564400},{"date":"2024-09-13","current":-4.052982,"twenty":-19.736764,"median":-6.803045,"eighty":-5.90427,"marketCap":1373939280},{"date":"2024-09-20","current":-4.285339,"twenty":-19.691462,"median":-6.795711,"eighty":-5.890536,"marketCap":1461418560},{"date":"2024-09-27","current":-3.839748,"twenty":-19.557128,"median":-6.786276,"eighty":-5.860332,"marketCap":1317335040},{"date":"2024-10-04","current":-4.188753,"twenty":-19.392893,"median":-6.782673,"eighty":-5.849331,"marketCap":1430543520},{"date":"2024-10-10","current":-3.397107,"twenty":-19.353312,"median":-6.780309,"eighty":-5.840253,"marketCap":1152668160},{"date":"2024-10-18","current":-3.186235,"twenty":-19.35305,"median":-6.770211,"eighty":-5.799664,"marketCap":1075480560},{"date":"2024-10-25","current":-3.049223,"twenty":-19.340003,"median":-6.761026,"eighty":-5.761318,"marketCap":1029168000},{"date":"2024-11-01","current":-2.970989,"twenty":-19.291097,"median":-6.743763,"eighty":-5.670928,"marketCap":1003438800},{"date":"2024-11-08","current":-2.76339,"twenty":-19.250915,"median":-6.736396,"eighty":-5.617725,"marketCap":926251200},{"date":"2024-11-15","current":-2.892718,"twenty":-19.247549,"median":-6.731169,"eighty":-5.595771,"marketCap":962272080},{"date":"2024-11-22","current":-2.739324,"twenty":-19.219362,"median":-6.719652,"eighty":-5.553055,"marketCap":910813680},{"date":"2024-11-29","current":-3.345148,"twenty":-19.204759,"median":-6.712989,"eighty":-5.540043,"marketCap":1111501440},{"date":"2024-12-06","current":-3.896363,"twenty":-19.114554,"median":-6.708686,"eighty":-5.49403,"marketCap":1291605840},{"date":"2024-12-13","current":-4.277366,"twenty":-19.100505,"median":-6.702742,"eighty":-5.451195,"marketCap":1415106000},{"date":"2024-12-20","current":-3.655849,"twenty":-19.087374,"median":-6.688987,"eighty":-5.43708,"marketCap":1204126560},{"date":"2024-12-27","current":-3.517968,"twenty":-19.069577,"median":-6.683627,"eighty":-5.42798,"marketCap":1157814000},{"date":"2025-01-03","current":-3.623869,"twenty":-19.056142,"median":-6.681936,"eighty":-5.390113,"marketCap":1193834880},{"date":"2025-01-10","current":-3.731729,"twenty":-19.049288,"median":-6.670929,"eighty":-5.342567,"marketCap":1224709920},{"date":"2025-01-17","current":-4.042058,"twenty":-19.026151,"median":-6.666985,"eighty":-5.31617,"marketCap":1327626720},{"date":"2025-01-24","current":-4.328275,"twenty":-18.993137,"median":-6.664395,"eighty":-5.260785,"marketCap":1430543520},{"date":"2025-01-28","current":-4.245725,"twenty":-18.984706,"median":-6.660018,"eighty":-5.241161,"marketCap":1409960160},{"date":"2025-02-07","current":-3.582548,"twenty":-18.970523,"median":-6.653781,"eighty":-5.191632,"marketCap":1183543200},{"date":"2025-02-14","current":-4.129707,"twenty":-18.911159,"median":-6.640938,"eighty":-5.116897,"marketCap":1363647600},{"date":"2025-02-21","current":-5.574702,"twenty":-18.882752,"median":-6.628363,"eighty":-5.079978,"marketCap":1847356560},{"date":"2025-02-28","current":-6.886255,"twenty":-18.878299,"median":-6.633004,"eighty":-5.105828,"marketCap":2274461280},{"date":"2025-03-07","current":-6.858717,"twenty":-18.864596,"median":-6.642372,"eighty":-5.113293,"marketCap":2274461280},{"date":"2025-03-14","current":-7.073388,"twenty":-18.817373,"median":-6.654985,"eighty":-5.116897,"marketCap":2346503040},{"date":"2025-03-21","current":-6.548558,"twenty":-18.791412,"median":-6.656915,"eighty":-5.127988,"marketCap":2171544480},{"date":"2025-03-28","current":-5.737719,"twenty":-18.77627,"median":-6.64898,"eighty":-5.151301,"marketCap":1898814960},{"date":"2025-04-03","current":-9.823261,"twenty":-18.702036,"median":-6.654985,"eighty":-5.172358,"marketCap":1965710880},{"date":"2025-04-11","current":-10.24929,"twenty":-18.645988,"median":-6.663121,"eighty":-5.189459,"marketCap":2032606800},{"date":"2025-04-17","current":-10.624425,"twenty":-18.610485,"median":-6.66693,"eighty":-5.195431,"marketCap":2109794400}],"updateTime":1745133325380}}}